Evidence map›Paper›PMID 32042566›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Single Functionalized pRNA/Gold Nanoparticle for Ultrasensitive MicroRNA Detection Using Electrochemical Surface-Enhanced Raman Spectroscopy.

Taek Lee, Mohsen Mohammadniaei, Hui Zhang, Jinho Yoon, Hye Kyu Choi, Sijin Guo, Peixuan Guo, Jeong-Woo Choi

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Recent advances in PCR-free nucleic acid detection for SARS-COV-2.Frontiers in bioengineering and biotechnology · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Taek LeeCollege of Pharmacy College of Medicine/Department of Physiology and Cell Biology/Dorothy M. Davis Heart and Lung Research Institute Ohio State University Columbus OH 43210 USA.
Mohsen MohammadniaeiDepartment of Chemical and Biomolecular Engineering Sogang University 35 Baekbeom-ro, Mapo-gu Seoul 121-742 Republic of Korea.
Hui ZhangCollege of Pharmacy College of Medicine/Department of Physiology and Cell Biology/Dorothy M. Davis Heart and Lung Research Institute Ohio State University Columbus OH 43210 USA.
Jinho YoonDepartment of Chemical and Biomolecular Engineering Sogang University 35 Baekbeom-ro, Mapo-gu Seoul 121-742 Republic of Korea.
Hye Kyu ChoiDepartment of Chemical and Biomolecular Engineering Sogang University 35 Baekbeom-ro, Mapo-gu Seoul 121-742 Republic of Korea.
Sijin GuoCollege of Pharmacy College of Medicine/Department of Physiology and Cell Biology/Dorothy M. Davis Heart and Lung Research Institute Ohio State University Columbus OH 43210 USA.
Peixuan GuoCollege of Pharmacy College of Medicine/Department of Physiology and Cell Biology/Dorothy M. Davis Heart and Lung Research Institute Ohio State University Columbus OH 43210 USA.
Jeong-Woo ChoiDepartment of Chemical and Biomolecular Engineering Sogang University 35 Baekbeom-ro, Mapo-gu Seoul 121-742 Republic of Korea.ORCID https://orcid.org/0000-0003-0100-0582

Funding

Optimizing RNA nanoparticles size and shape for enhancing cancer targeting and treatmentU01CA207946 · NCI · OHIO STATE UNIVERSITY · PI CARSON, WILLIAM E., GUO, PEIXUAN · 2016 to 2020
$2.7M
Phi29 Motor Nanopore for Single Molecule Sensing and dsDNA FingerprintingR01EB012135 · NIBIB · UNIVERSITY OF KENTUCKY · PI GUO, PEIXUAN · 2011 to 2019
$2.6M
RNA Nanotechnology in Cancer TherapyU01CA151648 · NCI · UNIVERSITY OF KENTUCKY · PI GUO, PEIXUAN, LI, HENRY · 2010 to 2014
$2.1M
Cancer specific and organ-avoiding RNA architectures for quantitative imagingR01EB019036 · NIBIB · UNIVERSITY OF KENTUCKY · PI EVERS, BERNARD MARK, GUO, PEIXUAN · 2014 to 2017
$1.3M
NCI NIH HHS U01 CA151648NCI NIH HHS U01 CA207946NIBIB NIH HHS R01 EB012135NIBIB NIH HHS R01 EB019036
6 · The paper itself

Abstract

Controlling the selective one-to-one conjugation of RNA with nanoparticles is vital for future applications of RNA nanotechnology. Here, the monofunctionalization of a gold nanoparticle (AuNP) with a single copy of RNA is developed for ultrasensitive microRNA-155 quantification using electrochemical surface-enhanced Raman spectroscopy (EC-SERS). A single AuNP is conjugated with one copy of the packaging RNA (pRNA) three-way junction (RNA 3WJ). pRNA 3WJ containing one strand of the 3WJ is connected to a Sephadex G100 aptamer and a biotin group at each arm (SEPapt/3WJ/Bio) which is then immobilized to the Sephadex G100 resin. The resulting complex is connected to streptavidin-coated AuNP (STV/AuNP). Next, the STV/AuNP-Bio/3WJa is purified and reassembled with another 3WJ to form a single-labeled 3WJ/AuNP. Later, the monoconjugate is immobilized onto the AuNP-electrodeposited indium tin oxide coated substrate for detecting microRNA-155 based on EC-SERS. Application of an optimum potential of +0.2 V results in extraordinary amplification (≈7 times) of methylene blue (reporter) SERS signal compared to the normal SERS signal. As a result, a highly sensitive detection of 60 × 10

Indexed as

biosensorselectrochemical surface‐enhanced Raman spectroscopy (EC‐SERS)microRNAsmonofunctionalizationpRNA 3WJ

Identifiers

PMID32042566
PMCPMC7001639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.